Fastigial Nucleus Stimulation for Coronary Heart Disease

• Status: Enrolling by invitation
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: All

Summary

To observe the effects of fastigial nucleus stimulation on serum inflammation, oxidative stress related factors, cardiac autonomic function and prognosis in patients with coronary heart disease

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Affiliated Hospital of North Sichuan Medical College
• Collaborator: the Third Hospital of Mianyang

Criteria

Inclusion Criteria:

• Coronary angiography was performed after admission, and coronary heart disease was diagnosed (coronary angiography showed at least one coronary artery with a diameter reduction of ≥50% from more than two different angles)

• Patients and their families agreed and signed informed consent

Exclusion Criteria:

• Severe chronic heart failure, and LVEF <30%

• Body temperature > 38 ° C and / or combined with severe infection in any system

• Severe liver and kidney dysfunction

• Malignant tumor

• Autoimmune diseases

• High blood pressure and diabetes with severe comorbidities

• Use of implantable electronic devices

• Intracranial implanted vascular stents

• Surface treatment electrode conductive materials Allergic or mastoid skin lesions